Option Care Health (NASDAQ:OPCH) Earns Outperform Rating from Barrington Research

Option Care Health (NASDAQ:OPCH)‘s stock had its “outperform” rating reaffirmed by equities researchers at Barrington Research in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $38.00 price objective on the stock. Barrington Research’s price objective would suggest a potential upside of 18.12% from the company’s previous close.

Several other equities analysts also recently commented on the stock. UBS Group upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price objective for the company from $38.00 to $40.00 in a report on Wednesday. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and increased their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. JPMorgan Chase & Co. boosted their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th. JMP Securities reaffirmed a “market outperform” rating and issued a $36.00 target price on shares of Option Care Health in a research report on Tuesday, April 22nd. Finally, Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and lifted their price target for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, Option Care Health has an average rating of “Moderate Buy” and an average target price of $35.50.

Option Care Health Trading Down 0.4 %

Shares of NASDAQ:OPCH opened at $32.17 on Wednesday. Option Care Health has a 52-week low of $21.39 and a 52-week high of $35.53. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The company has a market capitalization of $5.28 billion, a P/E ratio of 27.03, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. The company has a 50-day simple moving average of $33.34 and a 200 day simple moving average of $28.83.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The firm had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. During the same quarter in the prior year, the company earned $0.26 earnings per share. The business’s revenue for the quarter was up 16.3% compared to the same quarter last year. Sell-side analysts forecast that Option Care Health will post 1.22 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares of the company’s stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.64% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of OPCH. JPMorgan Chase & Co. raised its position in shares of Option Care Health by 29.6% in the 4th quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company’s stock valued at $35,065,000 after buying an additional 344,875 shares in the last quarter. Graypoint LLC acquired a new position in Option Care Health during the fourth quarter valued at approximately $1,161,000. Charles Schwab Investment Management Inc. lifted its stake in Option Care Health by 6.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company’s stock worth $58,235,000 after purchasing an additional 147,054 shares during the last quarter. Global Alpha Capital Management Ltd. boosted its holdings in shares of Option Care Health by 38.1% in the 4th quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company’s stock valued at $1,596,000 after purchasing an additional 18,992 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new position in shares of Option Care Health in the 4th quarter valued at $327,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.